Company profile

Mercury Bio

An intracellular immunotherapeutics biotech company targeting CNS and neurodegenerative disease.

Industry
Biotechnology Research
Employees
14
Headquarters
Santa Fe, New Mexico
Founded
2021
LinkedIn followers
635
Office locations
1

Mercury Bio company summary

Mercury Bio is a company in the Biotechnology Research industry, headquartered in Santa Fe, New Mexico, founded in 2021. On LinkedIn the company has around 14 employees and 635 followers. Its listed specialties include Drug delivery, Molecular biophysics, Molecular biology, Microbial genetics, Biochemistry.

What technology does Mercury Bio use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Mercury Bio

Mercury Bio is an intracellular immunotherapeutics biotech company in Santa Fe, New Mexico, founded in 2021. We’re focused on the central nervous system, with lead programs in Parkinson’s and Alzheimer’s. Our technology, MB-TIP™ (Targeting Intracellular Pathologies), reaches where these diseases begin: inside the neuron. Our patented, engineered extracellular vesicles yEVs™ cross the blood-brain barrier, enter the cytoplasm, avoid endosomal trapping, and deliver the cargo - proteins, small molecules, or RNA directly inside the cell. That’s what makes disease modification possible. In Parkinson’s and Alzheimer’s, the proteins driving the disease misfold and accumulate inside the neuron, where the damage begins. Reaching that compartment opens up a broad set of targets. Mercury Bio is built on a 14-patent-family IP portfolio and led by co-founders Bruce McCormick, Dana Barnard, and Dr. Richard Sayre with pharma/biotech executive Casey Perkins. The team brings decades of experience across drug discovery, development, and commercialization.

Specialties

Drug deliveryMolecular biophysicsMolecular biologyMicrobial geneticsBiochemistryGenetic & BioinformaticsComputational & Statistical ScienceTheoretical BiologyCentral Nervous System (CNS)Blood-brain BarrierIntracellular ImmunotherapeuticsExtracellular VesiclesProtein TherapeuticsRNA TherapeuticsSmall MoleculesNanobodiesParkinson’s DiseaseAlzheimer’s DiseaseNeurodegenerative Disease

Where is Mercury Bio located?

Mercury Bio lists 1 location.

Santa Fe, New Mexico, USHQ
3900 Paseo del Sol

Compare companies similar to Mercury Bio

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Mercury Bio
mercurybio.com
Biotechnology Research142021Santa Fe, New Mexico
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Mercury Bio

What does Mercury Bio do?

Mercury Bio is an intracellular immunotherapeutics biotech company in Santa Fe, New Mexico, founded in 2021. We’re focused on the central nervous system, with lead programs in Parkinson’s and Alzheimer’s. Our technology, MB-TIP™ (Targeting Intracellular Pathologies), reaches where these diseases begin: inside the neuron. Our patented, engineered extracellular vesicles yEVs™ cross the blood-brain barrier, enter the cytoplasm, avoid endosomal trapping, and deliver the cargo - proteins, small molecules, or RNA directly inside the cell. That’s what makes disease modification possible. In Parkinson’s and Alzheimer’s, the proteins driving the disease misfold and accumulate inside the neuron, where the damage begins. Reaching that compartment opens up a broad set of targets. Mercury Bio is built on a 14-patent-family IP portfolio and led by co-founders Bruce McCormick, Dana Barnard, and Dr. Richard Sayre with pharma/biotech executive Casey Perkins. The team brings decades of experience across drug discovery, development, and commercialization.

How many employees does Mercury Bio have?

Mercury Bio has around 14 employees on LinkedIn.

Where is Mercury Bio headquartered?

Mercury Bio is headquartered in Santa Fe, New Mexico.

When was Mercury Bio founded?

Mercury Bio was founded in 2021.

Build a lead list from companies like Mercury Bio

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.